Abstract
Transarterial bland embolization (TAE) is commonly used for treatment of neuroendocrine tumor liver metastases (NETLMs). Hormonal release causing hemodynamic instability and carcinoid symptoms is frequently observed during bland embolization of NETLMs. Data are lacking about the hemodynamic changes that can occur following TAE of NETLMs. The purpose of our study was to investigate the rate of periprocedural hemodynamic instability (PPHDI) associated with TAE for NETLMs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
